Primaire tabs
Exporteer 63 resultaten:
Filters: Auteur is L. Tesolin
Comment implémenter l'analyse de tendance,
, Webinar ARP Senegal, 12/09/2023, Sciensano, Brussels, (2023)
Development of a multiplex-based immunoassay for the characterization of diphtheria, tetanus and acellular pertussis antigens in human combined DTaP vaccines.,
, J Immunol Methods, 2023 Jun, Volume 517, (2023)
EU batch release procedure: Annual Report 2 - Batch Release of Vaccines,
, 2023 05 25, p.314, (2023)
l'analyse de tendance-concepts préliminaires,
, webinar ARP Senegal, 12/09/2023, Sciensano, Brussels, (2023)
OCABR: Respiratory Syncytial Virus (rDNA) Vaccine,
, 29/09/2023, Strasbourg (F), p.15, (2023)
Phase 2 testing: where are we now?,
, OMCL Annual Meeting EDQM 2023, 06/2023, Madrid, SPain, (2023)
Rational arguments for regulatory acceptance of consistency testing: benefits of non-animal testing over release testing of vaccines.,
, Expert Rev Vaccines, 2023 Apr 03, Volume 22, Issue 1, Number 377, (2023)
Report of WHO Drafting Group meeting to revise WHO Guidelines on procedures and data requirements for changes to approved vaccines,
, 10/10/2023, Geneva, switzerland, p.9, (2023)
A roadmap for regulatory implementation of in vitro models for evaluation of vaccine efficacy,
, 08/2023, Niagara falls, Canada, (2023)
Training on the assessment of quality part (M3) of the eCTD for the registration of vaccines for human use,
, Training on The assessment of quality part (M3) of the eCTD for the registration of vaccines for human use, 15/11/2023, Brussels, Belgium, (2023)
The vaccine Batch release procedure in Europe,
, Seminaire etudiants en pharmacie ULB, 04/12/2023, Brussels, Belgium, (2023)
WHO Drafting Group meeting to revise WHO Guidelines on PAC- outcome of workshops,
, WHO Drafting Group meeting to revise WHO Guidelines on procedures and data requirements for changes to approved vaccines, 20/09/2023, Frankfurt, Germany, (2023)
Auditors experience with remote audits‘Preparatory phase’,
, OMCL annual meeting 2022, 14/06/2022, EDQM, strasbourg, (2022)
The batch release procedure in Europe,
, Seminaire etudiants en pharmacie ULB, 05/12/2022, Brussels, Belgium, (2022)
The change in testing strategy for purity test on monovalent bulk of recombinant protein vaccine, Q&A,
, OMCL annual meeting 2022, 16/06/2022, EDQM, strasbourg, (2022)
Concept paper on the change in testing strategy for purity test on monovalent bulk of recombinant protein vaccine,
, 06/04/2022, Strasbourg, France, p.5, (2022)
The consistency approach for the substitution of in vivo testing for the quality control of established vaccines: practical considerations and progressive vision,
, Open Research Europe, 13/12/2022, (2022)
Manufacture and control of vaccine adjuvants from OMCL perspective,
, Seminaire ULB Pharmacien d'industrie, 05/12/2022, ULB pharmacie, (2022)
OCABR guideline for inactivated COVID-19 vaccines,
, 16/11/2022, EDQM, strasbourg, p.12, (2022)
Training on biological methods (Immunology),
, 13/10/2022, Sciensano, Bruxelles, (2022)
The vaccine Batch release procedure in Europe,
, Seminaire ULB Pharmacien d'industrie, 05/12/2022, ULB pharmacie, (2022)
"WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines",
, "WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines", 08/11/2022, Mascate, Oman sultanate, (2022)
Workshop on implementation of single dilution assay for in vivo testing,
, Workshop on implementation of single dilution assay for in vivo testing, 22/11/2022, Brussels, Belgium, (2022)
The batch release procedure in Europe ; Bacterial and polysaccharide vaccines,
, ULB dept Pharmacy, (2021)